Tianjin Pharmaceutical Da Ren Tang Appoints New Representative for A-Share Placement Oversight

SGX Filings
Mar 24

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited announced on Mar, 24 2026 that China Galaxy Securities Co., Ltd., its placement agent for the A-share placement initiated in Jul, 2015, has replaced one of its supervisory representatives.

Due to a change in work arrangements, Mr. Wang Jianlong will no longer serve in the role. Galaxy Securities has appointed Ms. Wang Han to assume the continuous supervision duties alongside existing representative Ms. Kang Yuan.

Although the formal supervision period for the placement has concluded, some proceeds from the fundraising remain unutilised, and the placement agent will continue to monitor the deposit and use of these funds.

The board expressed gratitude to Mr. Wang Jianlong for his contributions and confirmed that Ms. Wang Han, a sponsor representative with six years of investment-banking experience, will take over immediately.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10